-
‘Tis the Season…
Key Points In today’s Recommendations for Industry, we discuss current seasonal illnesses and what businesses should be doing. Read more below. Yesterday, with the increased discussions regarding the Omicron variant (including its many mutations and potential to affect transmissibility and potential for evading human antibodies), TAG released a Newsletter Special Edition. Please find that here.…
-
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic
Exclusive TAG Update: Yes, Omicron Has Spread, but NOT a Cause for Panic The omicron variant of COVID-19, which was first identified in South Africa, has been detected in multiple countries, including many in Europe as well as Israel, Hong Kong, and Canada – and we can reasonably assume that it is in the U.S.…
-
Triad of Trends Compels Double-Down on Symptom Monitoring
Key Points In today’s Recommendations for Industry, we emphasize the importance of monitoring symptoms as the rise of COVID-19, flu, or other respiratory illnesses begins into the winter months. Read more below. The FDA has expanded the eligibility for COVID-19 vaccine boosters, recommending and “authorizing use of a single booster dose for all individuals 18…
-
TAG Responds to Employer’s Questions on the ETS
Key Points In today’s Recommendations for Industry, we respond to employer questions on the OSHA ETS. Read more below. The Sixth Circuit Court of Appeals, based out of Cincinnati, was selected via lottery by the Judicial Panel on Multidistrict Litigation to hear legal challenges to the OSHA ETS issued on November 5. A three-judge panel…
-
Businesses Likely Not Held to OSHA ETS Deadlines: A Legal Opinion
Key Points In today’s Recommendations for Industry, we discuss the legal opinion from the Littler law firm that businesses will likely not be held to the current OSHA ETS deadlines. Read more below. Pfizer will begin producing its COVID-19 antiviral pill, “to be made and sold inexpensively in 95 poorer nations that are home to…
-
U.S. COVID Case Rate Descent Hits Plateau
Key Points In today’s Recommendations for Industry, we discuss TAG’s weekly matrix, the plateauing of case rates, and what businesses need to be doing. Read more below. The pandemic is not yet over, although there are positive signs in the U.S. that “with more and more Americans vaccinated, it’s not likely to linger as long…
-
OSHA ETS Temporarily Stayed…and Other COVID News
Key Points In today’s Recommendations for Industry, we discuss the stay of the OSHA ETS, the Pfizer antiviral, and a Science vaccine efficacy study. Read more below. On Saturday, a federal appeals court issued a stay of the Biden administration's vaccine mandate for private companies. In the brief order temporarily blocking the new vaccine rules…
-
OSHA Vaccine/Testing Standards Published
Key Points In today’s Recommendations for Industry, we include TAG’s weekly matrix information, and discuss the Occupational Safety and Health Administration (OSHA) issuance of the emergency temporary standard (ETS) establishing the requirements for the COVID-19 vaccine/testing mandate for employers with 100 or more employees. Read more below. The CDC has recommended the Pfizer COVID-19 vaccine…
-
Case Rates Fluctuating Around the Globe
In today’s Recommendations for Industry, we discuss the fluctuation in case rates. Read more below. At least 5 million people worldwide have died from Covid – though experts believe the total number is undoubtedly far higher. COVID-19 is responsible for more than five million confirmed deaths around the world –a loss that would wipe out…
-
COVID Protections: Keep on Keeping on
In today’s Recommendations for Industry, we discuss TAG’s weekly matrix and recommendations for close contact, but vaccinated, workers who have no symptoms. Read more below. In order to increase over-the-counter COVID-19 test access, the U.S. Department of Health and Human Services and the National Institutes of Health are “investing $70 million from the American Rescue…